Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu
Partner · Grade C

HumeCare+ review

Written by Elena Voss, Metabolic Health Editor

Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.

Current public pages do not establish the full semaglutide and tirzepatide plan prices. Earlier recorded prices retain their original verification date; confirm the complete quote and renewal terms before sharing intake details.

Consult Medication Shipping Labs
See plans at HumeCare+
  • Confirm HSA / FSA coverage
  • Public signup path reviewed
  • Confirm your total cost

We may earn a referral fee

HumeCare+ at a glance

Semaglutide
Current public price unconfirmed; earlier quote $199/mo, injection or oral
Tirzepatide
Current public price unconfirmed; earlier quote $299/mo, bundled with B12 and glycine
Coverage
46 states and Washington, D.C. — not Alabama, Arkansas, Louisiana or Mississippi
Brand-name
Compounded only

How we scored HumeCare+

Every factor comes from HumeCare+'s own published pricing, disclosures and oversight, and the six combine into the 50/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.

Postpartum & breastfeeding guidance48/100 · Weak

No postpartum or breastfeeding framing — a generic weight program.

PCOS & hormonal fit30/100 · Weak

Thin on the hormonal picture that drives many mothers' weight.

Clinical oversight & labs58/100 · Weak

Oversight and lab support fall short of the best on our list — the review below says exactly where.

True monthly cost60/100 · Weak

Cost is unpredictable or sits at the premium end.

Ongoing support72/100 · Weak

Support is thin once the prescription ships.

Cancellation fairness32/100 · Weak

Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.

How we checked this review

Current public pages do not establish the full semaglutide and tirzepatide plan prices. Earlier recorded prices retain their original verification date; confirm the complete quote and renewal terms before sharing intake details.

What to expect when you sign up

We walked HumeCare+'s public signup — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.

  1. 1The quiz opens with goal, gender, how much you want to lose and how fast, then asks height, weight, date of birth, state and name before it will show a plan
  2. 2Plans are presented as three cards — semaglutide injection, oral semaglutide, and tirzepatide bundled with B12 and glycine — each with a monthly figure and a struck-through higher one
  3. 3A consent screen then asks the buyer to tick six statements about pricing and billing before checkout, with Klarna, Affirm and Afterpay offered as payment plans

What we noticed

  • The medication safety page is unusually thorough for our list — separate monographs for compounded semaglutide and tirzepatide, and 55 mentions of pregnancy and 34 of breastfeeding across them
  • The site's medical leadership section names a chief medical officer, but the prescribing group itself — which the terms call the 'Clinical Network' — is never named, and neither is any compounding pharmacy
  • Three different member counts appear across the site: '20,000+ Americans' on the homepage, '23,323 members' inside the quiz, and '8,000 premium members' in the footnote to its internal muscle-preservation study
  • The service is sold only in the United States, but its copy reads as though it were written for the United Kingdom — British spellings throughout, and a listed prescriber whose stated credential, pharmacist independent prescriber, is a UK qualification with no US equivalent
  • Every option at checkout carries a 'chosen today' tally, and they add up to 20,386 people in one day — more than the 20,000 members the homepage claims to have served in total

Pricing

MedicationPricePlan
Compounded semaglutide$199Weekly injectionHistorical quote not reconfirmed October 14, 2026. The plan catalog prices this at $199 against a struck-through $299. Medication, the provider consultation, shipping and a Hume Pod body analyzer are all stated as included.
Oral semaglutide$199Daily oralHistorical quote not reconfirmed October 14, 2026. The oral pill is priced identically to the injection, also against a struck-through $299.
Compounded tirzepatide$299Weekly injection, with B12 and glycineHistorical quote not reconfirmed October 14, 2026. Struck through from $399. Tirzepatide is sold only in this bundled form — there is no plain tirzepatide line.

Swipe the table to see plan details →

Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what HumeCare+'s own site disclosed at last review; this market re-prices often, so confirm the current number at the source.

Prices move. Check today's number for your dose.See plans at HumeCare+

What we like

  • Earlier observation, not reconfirmed in October: One flat price per molecule — $199/mo for semaglutide, $299 for tirzepatide — that does not rise as your dose goes up, which is where a lot of our list quietly gets more expensive
  • Earlier program information, requiring current confirmation: the medication, the provider consultation, shipping and a Hume Pod body-composition scale are all stated as included, with no separate membership fee
  • Body composition is tracked weekly rather than weight alone, which is the right measurement for anyone worried about losing muscle on a GLP-1 — the concern the site is built around
  • Earlier program information, requiring current confirmation: an oral semaglutide pill is priced the same as the injection, which is unusual; oral is normally the expensive lane
  • The medication safety page is one of the more thorough on our list, with separate monographs per molecule and explicit pregnancy and breastfeeding direction
  • The compounded-medication disclosure is prominent and unambiguous — not FDA-approved, not reviewed for safety or manufacturing quality, not interchangeable with brand-name
  • No FDA warning letter against the brand or its operating company
  • Earlier program information, requiring current confirmation: sold month to month with no minimum term shown to the buyer — the checkout itself says 'Cancel anytime', and it itemizes what the price covers

The caveats

  • The money-back promise on the homepage is not the one in the terms: the banner offers a refund if you do not lose 10% in six months, while the terms only refund you if you lose nothing at all in 90 days, and exclude the consultation fee
  • That 90-day guarantee also requires you to be a first-time GLP-1 user, miss no logged dose, complete all thirteen weekly weigh-ins, and claim within 14 days — losing eight percent instead of ten returns nothing
  • The checkout says 'Cancel anytime' and sells it month to month, but the Terms of Service still require cancellation at least 48 hours before the renewal date and refund nothing for a month already begun
  • No price appears anywhere on the public site — not on the homepage, not on a pricing page — until you have given your height, weight, date of birth and state
  • Neither the prescribing group nor any compounding pharmacy is named; the terms refer only to an unnamed 'Clinical Network' and 'licensed compounding pharmacies'
  • The checkout copy and the contract disagree about renewal — you are asked to confirm you 'won't be automatically re-billed', while the Terms of Service say the membership renews itself unless you cancel
  • The 'chosen today' figures at checkout are hardcoded numbers, not a live count — 17,353, 1,985 and 1,048 sit in the page's own code and never move, and they total more people in one day than the 20,000 members the homepage claims to have served in total
  • Nothing on the site addresses postpartum care or PCOS, and no brand-name option is sold — the terms mention branded GLP-1s as a category its physicians may prescribe, but none is priced or offered

Weighed the likes and the caveats? See the plans for yourself.See plans at HumeCare+

HumeCare+ builds its program around connected measurements

HumeCare+ combines a prescription program with a Hume Pod body-composition analyzer and an app. The company emphasizes tracking fat and muscle alongside weight, with clinician support and progress monitoring. That is a distinct feature for someone who wants more information than a bathroom-scale total, but the device's presence does not prove better treatment outcomes or establish that a particular prescription prevents muscle loss. Ask which measurements a clinician actually reviews, how often the data is discussed and whether it changes the care plan. A connected device is most useful when its role in follow-up is clear.

The medication menu has included injectable semaglutide, oral semaglutide and tirzepatide combined with B12 and glycine. These are compounded preparations rather than FDA-approved finished products. A combination ingredient should be explained as part of the actual prescription, not treated as proof that side effects or muscle changes will be avoided. HumeCare's medication safety information is more explicit than a short promotional disclaimer, including pregnancy and breastfeeding direction. It still does not establish a dedicated postpartum or PCOS clinical service. Bring those concerns to the treating clinician rather than expecting the tracking app to answer them.

The earlier catalog amounts are not confirmed current prices

Earlier plan quotes were $199 monthly for injectable or oral semaglutide and $299 for tirzepatide with B12 and glycine, with consultation, medication, delivery and the Hume Pod described as included. Those historical amounts are not confirmed as the current full catalog. Public starting-protocol promotions also do not establish every molecule's price or commitment. Request a current quote showing the actual treatment, total charged at enrollment, supply duration and renewal amount. Do not compare the older $199 or $299 figure against a current competitor's monthly plan as though both were equally confirmed offers.

The payment language needs clarification too. Earlier checkout language described cancellation anytime and monthly payment, while the terms described automatic renewal, notice at least forty-eight hours before renewal and no prorated refund for a period already started. Promotional and contractual descriptions of a program can differ, so ask which written terms govern your selected purchase. If a longer commitment is offered, establish the complete obligation before choosing installment financing. Splitting a payment does not make an advance purchase cancelable month by month, and stopping renewal is different from recovering money for treatment already supplied.

The homepage guarantee is broader than the contract's promise

The headline money-back promise refers to losing ten percent of body weight within six months. The terms describe a narrower ninety-day guarantee tied to no measurable weight loss, with consultation fees excluded. They also attach conditions including first-time GLP-1 use, dose logging, thirteen weekly weigh-ins and a short claim window. Losing some weight while missing the headline target would not necessarily satisfy the contractual test. Obtain the guarantee applicable to your order before assigning it financial value; a results promise is not a substitute for understanding the purchase and refund conditions.

HumeCare's detailed coverage information and its broader homepage exclusions do not justify assuming universal access, so confirm your state and treatment together. The prescribing network and compounding pharmacies are not clearly named in the program's public terms. Those are reasonable organizations to ask about before sharing a full intake. HumeCare may appeal to someone who specifically wants connected body-composition tracking and is willing to clarify the complete offer. Someone mainly seeking a small, uncomplicated recurring bill has more questions to resolve here: current price, commitment, renewal and which guarantee applies. The strongest decision comes from those answers, not the device's retail value or a weight-loss projection.

The bottom line for mothers

Best for: Someone willing to request a current complete quote before comparing this program with publicly priced options.

Alternatives to HumeCare+

These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.

  • CoreAge RxFeatured partner

    CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.

    Visit CoreAge Rx
  • A compounded program that advertises ongoing provider care, metabolic testing every six months and shipping within its price. Semaglutide is $249 and tirzepatide $329 every four weeks without a longer commitment; lower equivalents require 12-, 24- or 48-week terms. Microdose and combination options need separate current quotes.

    Visit Enhance MD
  • Compounded medication with clinician access and coaching, with semaglutide shown at $299 regular and $79 on a time-limited sale. The important commitment comes before the eligibility decision: payment is taken first, paid terms are generally non-refundable, and medical disqualification refunds only the unused portion after deductions.

    Visit Embody

Providers like HumeCare+

Keep comparing HumeCare+

HumeCare+, answered

How much does HumeCare+ cost?
HumeCare+ does not establish a comparable recurring monthly medication rate. Published pricing: Current public price unconfirmed; earlier quote $199/mo, injection or oral for semaglutide; Current public price unconfirmed; earlier quote $299/mo, bundled with B12 and glycine for tirzepatide. Ask for the complete charge, supply period and renewal terms before committing.
Is HumeCare+ safe to use while breastfeeding?
Pregnancy is the clear line: no GLP-1 is established as safe while you are pregnant. If you are nursing, the Wegovy injection, Ozempic, Zepbound and Mounjaro labels say there is little or no data on the drug in breast milk, and they leave it to you and your clinician to weigh the benefits of breastfeeding against your need for treatment. Compounded versions carry no label of their own, so that conversation matters more, not less. HumeCare+ is not an exception to any of that — settle the timing with your own clinician.
Does HumeCare+ offer both semaglutide and tirzepatide?
Yes — HumeCare+ offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
How does HumeCare+ score for mothers?
HumeCare+ scores 50/100 on our Metabolic-Fit Score, a weighted read of six things mothers actually have to care about. CoreAge Rx, a featured partner, is worth a side-by-side look.

Have a question we didn't answer? HumeCare+'s team can.See plans at HumeCare+

Pricing, states and verification reflect HumeCare+'s public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.

← Back to all providers